BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16960766)

  • 41. Deriving welfare measures in discrete choice experiments: a comment to Lancsar and Savage (1).
    Ryan M
    Health Econ; 2004 Sep; 13(9):909-12; discussion 919-24. PubMed ID: 15362182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QALYs: the best option so far.
    Chong CA
    CMAJ; 2003 May; 168(11):1394-6; author reply 1396. PubMed ID: 12771064
    [No Abstract]   [Full Text] [Related]  

  • 43. The value of utility: assumptions underlying preferences and quality adjusted life years.
    Guillemin F
    J Rheumatol; 1999 Sep; 26(9):1861-3. PubMed ID: 10493660
    [No Abstract]   [Full Text] [Related]  

  • 44. [Health services need knowledge of how the public values health].
    Persson U; Hjelmgren J
    Lakartidningen; 2003 Oct; 100(43):3436-7. PubMed ID: 14626774
    [No Abstract]   [Full Text] [Related]  

  • 45. [German recommendations for health economic evaluation. Revised edition of the Hannoverian consensus. Hannoverian Consensus Group].
    Dtsch Med Wochenschr; 1999 Dec; 124(49):1503-6. PubMed ID: 10629671
    [No Abstract]   [Full Text] [Related]  

  • 46. Comments on the Prosser et Al approach to value disease reduction in children.
    Beutels P; Viney RC
    Pediatrics; 2004 Nov; 114(5):1375; author reply 1375-6. PubMed ID: 15520142
    [No Abstract]   [Full Text] [Related]  

  • 47. [Eleven years of economic evaluations of medical devices by the Spanish Network of Assessment Agencies. Methodological quality and cost-utility impact].
    Giménez E; García-Pérez L; Márquez S; Gutiérrez MA; Bayón JC; Espallargues M
    Gac Sanit; 2020; 34(4):326-333. PubMed ID: 31669165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility values for obesity and preliminary analysis of the Health Outcomes Data Repository.
    Dixon S; Currie CJ; McEwan P
    Expert Rev Pharmacoecon Outcomes Res; 2004 Dec; 4(6):657-65. PubMed ID: 19807539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A proposal to solve the comparability problem in cost-utility analysis.
    Bleichrodt H; Herrero C; Pinto JL
    J Health Econ; 2002 May; 21(3):397-403. PubMed ID: 12022265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using health state classification systems for utility elicitation in the elderly.
    Greenberg D; Pliskin JS
    Med Decis Making; 2006; 26(3):220-2. PubMed ID: 16751319
    [No Abstract]   [Full Text] [Related]  

  • 51. Biases from omitted risk effects in standard gamble utilities.
    Pope R
    J Health Econ; 2004 Jul; 23(4):695-735. PubMed ID: 15587695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. As good as it gets but good enough for which applications?
    Feeny D
    Med Decis Making; 2006; 26(4):307-9. PubMed ID: 16855119
    [No Abstract]   [Full Text] [Related]  

  • 53. A direct method for measuring discounting and QALYs more easily and reliably.
    Attema AE; Bleichrodt H; Wakker PP
    Med Decis Making; 2012; 32(4):583-93. PubMed ID: 22706639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heath State Utility Values for Cost-Effectiveness Models.
    Karnon J
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):1-3. PubMed ID: 29052154
    [No Abstract]   [Full Text] [Related]  

  • 55. The visibility and divisibility of quality-adjusted life-years.
    Mullins CD
    Clin Ther; 2005 Aug; 27(8):1276-7. PubMed ID: 16199252
    [No Abstract]   [Full Text] [Related]  

  • 56. [The value of the utility of estimating QALYs: an open question].
    Mennini FS
    G Ital Nefrol; 2013; 30(5):. PubMed ID: 24941480
    [No Abstract]   [Full Text] [Related]  

  • 57. Measuring utility values for QALYs: two methodological issues.
    Smith R; Dobson M
    Health Econ; 1993 Dec; 2(4):349-55. PubMed ID: 8142996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testing assumptions of quality-adjusted life-year calculations. Commentary on "An Exponential Representation of Health State Utility" from M. Happich.
    Béresniak A
    Eur J Health Econ; 2003 Nov; 4(4):295. PubMed ID: 15609199
    [No Abstract]   [Full Text] [Related]  

  • 59. Incorporating quality of life changes into economic evaluations of health care.
    McKenna S
    Health Policy; 1996 Sep; 37(3):199-204. PubMed ID: 10160023
    [No Abstract]   [Full Text] [Related]  

  • 60. The Utility of Cost-Utility Analyses in Critical Care.
    Kahn JM
    Crit Care Med; 2021 Apr; 49(4):702-704. PubMed ID: 33731608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.